3 MORE LONDON RIVERSIDE, LONDON, X0
News
Shareholders Approve Proposed Acquisition
News, Material Contracts
Merck Acquires Verona Pharma, Expands Portfolio with Ohtuvayre, a COPD Treatment
Earnings Release
Submission of Matters to a Vote of Security Holders
Announces Amended Strategic Financing with Oaktree and OMERS
Annual Report to Security Holders
Q2
Q1
FY 2023
Q3
Notice of Suspension of Duty to File Reports
Registration Statement for Securities to be Offered to Employees
S-3ASR
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Additional Information Statement
Additional Proxy Materials
Definitive Merger Proxy Statement
Statement of Changes in Beneficial Ownership
S-8 POS
Automatic Shelf Registration Statement
Post-Effective Amendment to Registration Statement